The quality of life impact of acne and rosacea compared to other major medical conditions

Journal of Drugs in Dermatology

Volumn 13, Issue 6, 2014, Pages 692-697

  Cresce, Nicole D ^a   Davis, Scott A ^a   Huang, William W ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; ANGINA PECTORIS; ARTHRITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BACKACHE; CHLOASMA; CHRONIC URTICARIA; DERMATOLOGY LIFE QUALITY INDEX; DIABETES MELLITUS; DISABILITY; EPILEPSY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFECTION; ISCHEMIC HEART DISEASE; LEG ULCER; LUPUS ERYTHEMATOSUS; MEDICAID; MEDICAL LITERATURE; MEDLINE; MELANOCYTIC NEVUS; OCCUPATIONAL ECZEMA; PRURITUS; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; RESOURCE ALLOCATION; ROSACEA; SEBORRHEIC DERMATITIS; SHORT FORM 36; SKIN INJURY; SKIN ULCER; SYSTEMATIC REVIEW; VERRUCA VULGARIS; VITILIGO; WILLINGNESS TO PAY; ACNE VULGARIS; ECONOMICS; FINANCIAL MANAGEMENT; PATHOLOGY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ACNE VULGARIS; FINANCING, PERSONAL; HUMANS; PSORIASIS; QUALITY OF LIFE; RESOURCE ALLOCATION; ROSACEA;

EID: 84903389092     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Bickers DR, Lim HW, Margolis D et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2006;55(3):490-500. (Pubitemid 44209289)
2. Roosta N, Black DS, Peng D, Riley LW. Skin disease and stigma in emerging adulthood: impact on healthy development. J Cutan Med Surg 2010;14(6):285-290.
3. Uhlenhake E, Yentzer BA, Feldman SR. Acne vulgaris and depression: a retrospective examination. J Cosmet Dermatol 2010;9(1):59-63.
4. Gupta MA, Gupta AK, Chen SJ, Johnson AM. Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey - Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002. Br J Dermatol 2005;153(6):1176-1181. (Pubitemid 41779573)
5. Gupta MA, Gupta AK. Evaluation of cutaneous body image dissatisfaction in the dermatology patient. Clin Dermatol 2013;31(1):72-79.
6. Ohayon MM. Epidemiology of depression and its treatment in the general population. J Psychiatr Res 2007;41(3-4):207-213. (Pubitemid 44855001)
7. Golchai J, Khani SH, Heidarzadeh A, Eshkevari SS, Alizade N, Eftekhari H. Comparison of anxiety and depression in patients with acne vulgaris and healthy individuals. Indian J Dermatol 2010;55(4):352-354.
8. Su D, Drummond PD. Blushing propensity and psychological distress in people with rosacea. Clin Psychol Psychother 2012;19(6):488-495.
9. Blount BW, Pelletier AL. Rosacea: a common, yet commonly overlooked, condition. Am Fam Physician 2002;66(3):435-440.
10. Cunliffe WJ. Acne and unemployment. Br J Dermatol 1986;115(3):386.
11. National Rosacea Society. Rosacea and Employment. http://www.rosaceaorg/ weblog/rosacea-and-employment 2011 June 23. Accessed January 3, 2014.
12. Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998;134(4):454-458. (Pubitemid 28207628)
13. Barnes LE, Levender MM, Fleischer AB, Jr., Feldman SR. Quality of life measures for acne patients. Dermatol Clin 2012;30(2):293-300, ix.
14. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999;140(4):672-676. (Pubitemid 29191387)
15. Chen SC, Bayoumi AM, Soon SL et al. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Investig Dermatol Symp Proc 2004;9(2):160-168. (Pubitemid 38457275)
16. Klassen AF, Newton JN, Mallon E. Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J Am Acad Dermatol 2000;43(2 Pt 1):229-233. (Pubitemid 30625998)
17. Both H, Essink-Bot ML, Busschbach J, Nijsten T. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol 2007;127(12):2726-2739. (Pubitemid 350134835)
18. Hayashi N, Higaki Y, Kawamoto K, Kamo T, Shimizu S, Kawashima M. A cross-sectional analysis of quality of life in Japanese acne patients using the Japanese version of Skindex-16. J Dermatol 2004;31(12):971-976. (Pubitemid 40143998)
19. Seidler AM, Bayoumi AM, Goldstein MK, Cruz PD, Jr., Chen SC. Willingness to pay in dermatology: assessment of the burden of skin diseases. J Invest Dermatol 2012;132(7):1785-1790.
20. Jenkinson C, Layte R, Lawrence K. Development and testing of the Medical Outcomes Study 36-Item Short Form Health Survey summary scale scores in the United Kingdom. Results from a large-scale survey and a clinical trial. Med Care 1997;35(4):410-416. (Pubitemid 127458342)
21. Sullivan PW, Ghushchyan V. Preference-Based EQ-5D index scores for chronic conditions in the United States. Med Decis Making 2006;26(4):410-420. (Pubitemid 44050845)
22. Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc 2004;9(2):169-180. (Pubitemid 38457276)
23. Tejada CS, Mendoza-Sassi RA, Almeida HL, Jr., Figueiredo PN, Tejada VF. Impact on the quality of life of dermatological patients in southern Brazil. An Bras Dermatol 2011;86(6):1113-1121.
24. Davies E, Patel C, Salek MS, Finlay AY. Does ad hoc quality-of-life discussion in inflammatory skin disease consultations reflect standardized patient-reported outcomes? Clin Exp Dermatol 2008;33(1):16-21. (Pubitemid 350308527)
25. Harlow D, Poyner T, Finlay AY, Dykes PJ. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol 2000;143(5):979-982.
26. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19(3):210-216. (Pubitemid 24194579)
27. Parks L, Balkrishnan R, Hamel-Gariepy L, Feldman SR. The Importance Do Not Penalties of Skin Disease as Assessed by "Willingness-To-Pay". J Cutan Med Surg 2003;10227(5):369-371. (Pubitemid 37500394)
28. Chen CL, Kuppermann M, Caughey AB, Zane LT. A community-based study of acne-related health preferences in adolescents. Arch Dermatol 2008;144(8):988-994.
29. Yentzer BA, Hick J, Reese EL, Uhas A, Feldman SR, Balkrishnan R. Acne vulgaris in the United States: a descriptive epidemiology. Cutis 2010;86(2):94-99.
30. Beikert FC, Langenbruch AK, Radtke MA, Augustin M. Willingness to pay and quality of life in patients with rosacea. J Eur Acad Dermatol Venereol 2013;27(6):734-738.
31. Chren MM, Lasek RJ, Quinn LM, Covinsky KE. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 1997;108(1):103-107. (Pubitemid 27019854)
32. Rapp SR, Feldman SR, Exum ML, Fleischer AB, Jr., Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41(3 Pt 1):401-407. (Pubitemid 29418506)
33. Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of Sickness Impact Profile and Psoriasis Disability Index in Psoriasis. Br J Dermatol 1990;123(6):751-756.
34. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132(2):236-244.
35. VanBeek MJ. Integrating patient preferences with health utilities: a variation on health-related quality of life. Arch Dermatol 2008;144(8):1037- 1041.
36. Chen DM, Gordon KB, Leonardi CL, Menter MA. Adalimumab Efficacy and Safety in Patients with Moderate to Severe Chronic Plaque Psoriasis: Preliminary Findings from a 12-week Dose-Ranging Trial. J Amer Acad Dermatol 2004;50(Suppl)(3):1.
37. Angelova-Fischer I, Rippke F, Fischer TW, Neufang G, Zillikens D. A double-blind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne. J Eur Acad Dermatol Venereol 2013;27 Suppl 2:6-11. doi: 10.1111/jdv.12168.:6-11.
38. Marron SE, Tomas-Aragones L, Boira S. Anxiety, Depression, Quality of Life and Patient Satisfaction in Acne Patients Treated with Oral Isotretinoin. Acta Derm Venereol 2013;10-1638.
39. Rademaker M, Wishart JM, Birchall NM. Isotretinoin 5 mg daily for low-grade adult acne vulgaris - a placebo-controlled, randomized double-blind study. J Eur Acad Dermatol Venereol 2013;10.
40. Seite S, Deshayes P, Dreno B et al. Interest of corrective makeup in the management of patients in dermatology. Clin Cosmet Investig Dermatol 2012;5:123-8. doi: 10.2147/CCID.S33172. Epub;%2012 Sep 7.:123-128.
41. Bohm M, Ehrchen J, Luger TA. Beneficial effects of the melanocortin analogue Nle(4) -d-Phe(7) -alpha-MSH in acne vulgaris. J Eur Acad Dermatol Venereol 2012;10-3083.
42. Safizadeh H, Shamsi-Meymandy S, Naeimi A. Quality of life in Iranian patients with acne. Dermatol Res Pract 2012;2012:571516. doi: 10.1155/2012/571516. Epub;%2012 Feb 15.:571516.
43. Huh SY, Na JI, Huh CH, Park KC. The effect of photodynamic therapy using indole-3-acetic Acid and green light on acne vulgaris. Ann Dermatol 2012;24(1):56-60.
44. Berg M, Lindberg M. Possible gender differences in the quality of life and choice of therapy in acne. J Eur Acad Dermatol Venereol 2011;25(8):969-972.
45. Kobayashi M, Kabashima K, Nakamura M, Tokura Y. Effects of oral antibiotic roxithromycin on quality of life in acne patients. J Dermatol 2009;36(7):383-391.
46. Abdel-Hafez K, Mahran AM, Hofny ER, Mohammed KA, Darweesh AM, Aal AA. The impact of acne vulgaris on the quality of life and psychologic status in patients from upper Egypt. Int J Dermatol 2009;48(3):280-285.
47. Kaymak Y, Taner E, Taner Y. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents. Int J Dermatol 2009;48(1):41-46.
48. Ammad S, Gonzales M, Edwards C, Finlay AY, Mills C. An assessment of the efficacy of blue light phototherapy in the treatment of acne vulgaris. J Cosmet Dermatol 2008;7(3):180-188.
49. Oprica C, Emtestam L, Hagstromer L, Nord CE. Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris. Acta Derm Venereol 2007;87(3):246-254. (Pubitemid 47226894)
50. Matsuoka Y, Yoneda K, Sadahira C, Katsuura J, Moriue T, Kubota Y. Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris. J Dermatol 2006;33(11):745-752. (Pubitemid 44630136)
51. Ilgen E, Derya A. There is no correlation between acne severity and AQOLS/DLQI scores. J Dermatol 2005;32(9):705-710. (Pubitemid 41442069)
52. Zaghloul SS, Cunliffe WJ, Goodfield MJ. Objective assessment of compliance with treatments in acne. Br J Dermatol 2005;152(5):1015-1021. (Pubitemid 40704945)
53. Ozolins M, Eady EA, Avery A et al. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. Health Technol Assess 2005;9(1):iii-212.
54. Yazici K, Baz K, Yazici AE et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol 2004;18(4):435-439. (Pubitemid 38967976)
55. Boehncke WH, Ochsendorf F, Paeslack I, Kaufmann R, Zollner TM. Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases. Eur J Dermatol 2002;12(6):577-580. (Pubitemid 35440799)
56. Grosshans E, Marks R, Mascaro JM et al. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. British Journal of Dermatology 1998;139 Suppl 52:26-33.
57. Newton JN, Mallon E, Klassen A, Ryan TJ, Finlay AY. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol 1997;137(4):563-567. (Pubitemid 27469507)
58. Shim TN, Abdullah A. The effect of pulsed dye laser on the dermatology life quality index in erythematotelangiectatic rosacea patients: an assessment. J Clin Aesthet Dermatol 2013;6(4):30-32.
59. Langenbruch AK, Beket E, Augustin M. Quality of health care of rosacea in Germany from the patient's perspective: results of the national health care study Rosareal 2009. Dermatology 2011;223(2):124-130.
60. Aksoy B, Altaykan-Hapa A, Egemen D, Karagoz F, Atakan N. The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol 2010;163(4):719-725.
61. Menezes N, Moreira A, Mota G, Baptista A. Quality of life and rosacea: pulsed dye laser impact. J Cosmet Laser Ther 2009;11(3):139-141.
62. Weissenbacher S, Merkl J, Hildebrandt B et al. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. Br J Dermatol 2007;156(4):728-732. (Pubitemid 46452339)
63. Tan SR, Tope WD. Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life. J Am Acad Dermatol 2004;51(4):592-599. (Pubitemid 39278080)
64. Bae JM, Ha B, Lee H, Park CK, Kim HJ, Park YM. Prevalence of common skin diseases and their associated factors among military personnel in Korea: a cross-sectional study. J Korean Med Sci 2012;27(10):1248-1254.